2012 Q2 Form 10-Q Financial Statement
#000110465912054509 Filed on August 06, 2012
Income Statement
| Concept | 2012 Q2 | 2011 Q2 |
|---|---|---|
| Revenue | $47.34M | $24.82M |
| YoY Change | 90.71% | 5.63% |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $3.200M | $2.900M |
| YoY Change | 10.34% | -6.45% |
| % of Gross Profit | ||
| Research & Development | $40.44M | $36.01M |
| YoY Change | 12.29% | -7.91% |
| % of Gross Profit | ||
| Depreciation & Amortization | ||
| YoY Change | ||
| % of Gross Profit | ||
| Operating Expenses | $43.64M | $38.88M |
| YoY Change | 12.24% | -7.86% |
| Operating Profit | $3.696M | -$14.06M |
| YoY Change | -126.29% | |
| Interest Expense | $5.219M | $3.437M |
| YoY Change | 51.85% | -152.88% |
| % of Operating Profit | 141.21% | |
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$1.207M | -$17.88M |
| YoY Change | -93.25% | -29.05% |
| Income Tax | $0.00 | $9.000K |
| % Of Pretax Income | ||
| Net Earnings | -$1.200M | -$17.90M |
| YoY Change | -93.3% | -28.97% |
| Net Earnings / Revenue | -2.53% | -72.11% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$0.01 | -$0.18 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 100.2M shares | 99.60M shares |
| Diluted Shares Outstanding | 100.2M shares | 99.60M shares |
Balance Sheet
| Concept | 2012 Q2 | 2011 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $336.0M | $395.2M |
| YoY Change | -14.98% | -24.61% |
| Cash & Equivalents | $85.65M | $85.02M |
| Short-Term Investments | $250.4M | $310.2M |
| Other Short-Term Assets | $5.700M | $7.600M |
| YoY Change | -25.0% | 58.33% |
| Inventory | $7.100M | $2.200M |
| Prepaid Expenses | ||
| Receivables | $1.600M | $5.700M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $350.4M | $410.7M |
| YoY Change | -14.68% | -23.51% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $94.00M | $88.00M |
| YoY Change | 6.82% | 143.77% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | -$5.563M | |
| YoY Change | ||
| Other Assets | $2.500M | $3.300M |
| YoY Change | -24.24% | 3.13% |
| Total Long-Term Assets | $122.0M | $118.9M |
| YoY Change | 2.59% | 71.08% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $350.4M | $410.7M |
| Total Long-Term Assets | $122.0M | $118.9M |
| Total Assets | $472.4M | $529.6M |
| YoY Change | -10.8% | -12.66% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $6.200M | $3.100M |
| YoY Change | 100.0% | -42.59% |
| Accrued Expenses | $20.60M | $15.30M |
| YoY Change | 34.64% | -13.07% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $5.300M | $4.900M |
| YoY Change | 8.16% | -2.0% |
| Total Short-Term Liabilities | $55.06M | $92.00M |
| YoY Change | -40.15% | -12.55% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $225.7M | $201.3M |
| YoY Change | 12.12% | 39.12% |
| Other Long-Term Liabilities | $37.30M | $24.10M |
| YoY Change | 54.77% | -74.42% |
| Total Long-Term Liabilities | $263.0M | $225.4M |
| YoY Change | 16.68% | -5.65% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $55.06M | $92.00M |
| Total Long-Term Liabilities | $263.0M | $225.4M |
| Total Liabilities | $318.1M | $317.4M |
| YoY Change | 0.21% | -7.76% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $154.3M | $212.2M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $472.4M | $529.6M |
| YoY Change | -10.8% | -12.66% |
Cashflow Statement
| Concept | 2012 Q2 | 2011 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$1.200M | -$17.90M |
| YoY Change | -93.3% | -28.97% |
| Depreciation, Depletion And Amortization | ||
| YoY Change | ||
| Cash From Operating Activities | -$2.600M | -$26.20M |
| YoY Change | -90.08% | -624.0% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$800.0K | -$3.400M |
| YoY Change | -76.47% | 277.78% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $24.80M | $28.00M |
| YoY Change | -11.43% | -147.38% |
| Cash From Investing Activities | $24.10M | $24.70M |
| YoY Change | -2.43% | -141.17% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 7.800M | 300.0K |
| YoY Change | 2500.0% | -86.96% |
| NET CHANGE | ||
| Cash From Operating Activities | -2.600M | -26.20M |
| Cash From Investing Activities | 24.10M | 24.70M |
| Cash From Financing Activities | 7.800M | 300.0K |
| Net Change In Cash | 29.30M | -1.200M |
| YoY Change | -2541.67% | -97.72% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$2.600M | -$26.20M |
| Capital Expenditures | -$800.0K | -$3.400M |
| Free Cash Flow | -$1.800M | -$22.80M |
| YoY Change | -92.11% | -486.44% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Interest Expense
InterestExpense
|
6851000 | USD | |
| us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
-285000 | USD | |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
65477000 | USD |
| CY2011Q4 | us-gaap |
Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
|
6921000 | USD |
| CY2012Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
7108000 | USD |
| CY2012Q2 | us-gaap |
Assets Current
AssetsCurrent
|
350419000 | USD |
| CY2012Q2 | us-gaap |
Assets
Assets
|
472394000 | USD |
| CY2012Q2 | us-gaap |
Liabilities
Liabilities
|
318080000 | USD |
| CY2012Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
154314000 | USD |
| CY2012Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
472394000 | USD |
| CY2012Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2012Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2011Q2 | isis |
Research And Development Revenue Under Collaborative Agreements
ResearchAndDevelopmentRevenueUnderCollaborativeAgreements
|
24305000 | USD |
| CY2011Q2 | isis |
Licensing And Royalty Revenue
LicensingAndRoyaltyRevenue
|
518000 | USD |
| CY2011Q2 | us-gaap |
Revenues
Revenues
|
24823000 | USD |
| isis |
Research And Development Revenue Under Collaborative Agreements
ResearchAndDevelopmentRevenueUnderCollaborativeAgreements
|
44319000 | USD | |
| isis |
Licensing And Royalty Revenue
LicensingAndRoyaltyRevenue
|
1651000 | USD | |
| us-gaap |
Revenues
Revenues
|
45970000 | USD | |
| CY2011Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
36009000 | USD |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5884000 | USD | |
| CY2011Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
38883000 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
76138000 | USD | |
| CY2011Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14060000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-30168000 | USD | |
| CY2011Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
278187000 | USD |
| CY2011Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
5415000 | USD |
| CY2011Q4 | us-gaap |
Assets Current
AssetsCurrent
|
360139000 | USD |
| CY2011Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
96615000 | USD |
| CY2011Q4 | isis |
Licenses Net
LicensesNet
|
9036000 | USD |
| CY2011Q4 | isis |
Patents Net
PatentsNet
|
16259000 | USD |
| CY2011Q4 | isis |
Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
|
2845000 | USD |
| CY2011Q4 | us-gaap |
Assets
Assets
|
484894000 | USD |
| CY2011Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8300000 | USD |
| CY2011Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
9183000 | USD |
| CY2011Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
18655000 | USD |
| CY2011Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
3390000 | USD |
| CY2011Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
36584000 | USD |
| CY2011Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
76112000 | USD |
| CY2011Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
17474000 | USD |
| CY2011Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
141448000 | USD |
| CY2011Q4 | isis |
Capital Lease And Other Long Term Borrowings Non Current
CapitalLeaseAndOtherLongTermBorrowingsNonCurrent
|
4125000 | USD |
| CY2011Q4 | isis |
Long Term Financing Obligation
LongTermFinancingObligation
|
69877000 | USD |
| CY2011Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
-4424000 | USD |
| CY2011Q4 | us-gaap |
Liabilities
Liabilities
|
313460000 | USD |
| CY2011Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
100000 | USD |
| CY2011Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1013592000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-770000 | USD |
| CY2011Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-841488000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
171434000 | USD |
| CY2011Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
484894000 | USD |
| CY2012Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
55063000 | USD |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-23464000 | USD | |
| CY2011Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2012Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
100320445 | shares |
| CY2011Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
100042976 | shares |
| CY2011Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2012Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
100320445 | shares |
| CY2011Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
100042976 | shares |
| us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1889000 | USD | |
| CY2011Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
616000 | USD |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-25202000 | USD | |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-550000 | USD | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
70254000 | USD | |
| CY2011Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2874000 | USD |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-37883000 | USD | |
| CY2011Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.18 | |
| CY2011Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1033000 | USD |
| us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1321000 | USD | |
| CY2011Q2 | us-gaap |
Interest Expense
InterestExpense
|
3437000 | USD |
| CY2011Q2 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
34000 | USD |
| CY2012Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
3000 | USD |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-66019000 | USD | |
| us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
208723000 | USD | |
| CY2011Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-17880000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-37872000 | USD | |
| CY2011Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
9000 | USD |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
11000 | USD | |
| CY2011Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-17889000 | USD |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.38 | ||
| CY2011Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99602000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99586000 | shares | |
| CY2011Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
99602000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
99586000 | shares | |
| CY2012Q2 | us-gaap |
Revenues
Revenues
|
47340000 | USD |
| CY2012Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
43644000 | USD |
| CY2012Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1207000 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
85334000 | USD | |
| us-gaap |
Revenues
Revenues
|
70575000 | USD | |
| CY2011Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-290000 | USD |
| CY2011Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-18179000 | USD |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-38433000 | USD | |
| us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
298177000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5982000 | USD | |
| isis |
Payments To Acquire Licenses And Other Assets
PaymentsToAcquireLicensesAndOtherAssets
|
1755000 | USD | |
| isis |
Purchases Of Strategic Investments
PurchasesOfStrategicInvestments
|
359000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
81358000 | USD | |
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
876000 | USD | |
| isis |
Proceeds From Equipment Financing Arrangement
ProceedsFromEquipmentFinancingArrangement
|
1625000 | USD | |
| us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
2870000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-369000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
14970000 | USD | |
| us-gaap |
Interest Paid
InterestPaid
|
2398000 | USD | |
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
2000 | USD | |
| isis |
Noncash Capital And Patent Expenditures
NoncashCapitalAndPatentExpenditures
|
1080000 | USD | |
| isis |
Capitalized Costs And Financing Liability
CapitalizedCostsAndFinancingLiability
|
48575000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
20168000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5884000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
23572000 | USD | |
| CY2011Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
85022000 | USD |
| CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
70052000 | USD |
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
| isis |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | item | |
| CY2012Q2 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.02625 | pure |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4727000 | USD | |
| CY2012Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2460000 | USD |
| CY2011Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2500000 | USD |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5232000 | USD | |
| CY2012Q2 | isis |
Available For Sale Securities Debt Maturities Within One Year Percentage
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearPercentage
|
0.66 | pure |
| CY2012Q2 | isis |
Available For Sale Securities Debt Maturities After One Through Two Years Percentage
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsPercentage
|
0.24 | pure |
| CY2012Q2 | isis |
Available For Sale Securities Debt Maturities After Two Through Three Years Percentage
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughThreeYearsPercentage
|
0.10 | pure |
| CY2012Q2 | isis |
Available For Sale Securities Debt Maturities Total Percentage
AvailableForSaleSecuritiesDebtMaturitiesTotalPercentage
|
1.00 | pure |
| CY2012Q2 | isis |
Available For Sale Securities Debt Maturities Within Two Years Percentage
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsPercentage
|
0.90 | pure |
| dei |
Entity Registrant Name
EntityRegistrantName
|
ISIS PHARMACEUTICALS INC | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000874015 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2012-06-30 | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2012 | ||
| CY2012Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
100603769 | shares |
| isis |
Number Of Categories Of Milestone Events
NumberOfCategoriesOfMilestoneEvents
|
3 | item | |
| isis |
Number Of Stages Of Life Cycle Of Drugs
NumberOfStagesOfLifeCycleOfDrugs
|
3 | item | |
| isis |
Cash Equivalents Remaining Maturity Period Maximum
CashEquivalentsRemainingMaturityPeriodMaximum
|
90 | item | |
| isis |
Short Term Investments Initial Remaining Maturity Period Greater Than
ShortTermInvestmentsInitialRemainingMaturityPeriodGreaterThan
|
90 | item | |
| CY2012Q2 | isis |
Cost Method Investments Ownership Percentage Less Than
CostMethodInvestmentsOwnershipPercentageLessThan
|
0.20 | pure |
| CY2011Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
4139000 | USD |
| CY2012Q2 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
-5563000 | USD |
| isis |
Variable Interest Entity Not Primary Beneficiary Number Of Entities
VariableInterestEntityNotPrimaryBeneficiaryNumberOfEntities
|
6 | item | |
| CY2012Q2 | isis |
Number Of Privately Held Companies In Which Entity Has Equity Investment
NumberOfPrivatelyHeldCompaniesInWhichEntityHasEquityInvestment
|
3 | company |
| CY2012Q2 | isis |
Number Of Publicly Held Companies In Which Entity Has Equity Investment
NumberOfPubliclyHeldCompaniesInWhichEntityHasEquityInvestment
|
2 | company |
| CY2012Q2 | isis |
Available For Sale Securities Equity Securities Ownership Percentage Less Than
AvailableForSaleSecuritiesEquitySecuritiesOwnershipPercentageLessThan
|
0.20 | pure |
| CY2011Q4 | us-gaap |
Cost Method Investments
CostMethodInvestments
|
625000 | USD |
| CY2012Q2 | us-gaap |
Cost Method Investments
CostMethodInvestments
|
625000 | USD |
| CY2011Q4 | us-gaap |
Cost Method Investments Fair Value Disclosure
CostMethodInvestmentsFairValueDisclosure
|
625000 | USD |
| CY2012Q2 | us-gaap |
Cost Method Investments Fair Value Disclosure
CostMethodInvestmentsFairValueDisclosure
|
625000 | USD |
| CY2011Q4 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
719000 | USD |
| CY2012Q2 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
2132000 | USD |
| CY2011Q4 | us-gaap |
Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
|
684000 | USD |
| CY2012Q2 | us-gaap |
Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
|
359000 | USD |
| us-gaap |
Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
|
880000 | USD | |
| CY2011 | us-gaap |
Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
|
880000 | USD |
| CY2011Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
280094000 | USD |
| CY2012Q2 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
253610000 | USD |
| CY2012Q2 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions
|
48 | item |
| CY2012Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
107265000 | USD |
| CY2012Q2 | us-gaap |
Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses1
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1
|
-359000 | USD |
